NDC 70748-346 – Liraglutide

Liraglutide 6 mg/mL · Injection · Subcutaneous

Human Prescription Drug 1 recall

Product NDC70748-346

Product details

Brand name
Liraglutide
Generic name
Liraglutide
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
ANDA · ANDA215421
Marketed since
October 2, 2025
Listing expires
December 31, 2026
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Liraglutide →

Package NDC codes (2)

Package NDCDescriptionSince
70748-346-022 SYRINGE, PLASTIC in 1 CARTON (70748-346-02) / 3 mL in 1 SYRINGE, PLASTICOct 2, 2025
70748-346-033 SYRINGE, PLASTIC in 1 CARTON (70748-346-03) / 3 mL in 1 SYRINGE, PLASTICOct 2, 2025

Recalls mentioning this NDC

Other Liraglutide products